191 related articles for article (PubMed ID: 27430377)
21. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
[TBL] [Abstract][Full Text] [Related]
22. Enhancing antitumor effects in pancreatic cancer cells by combined use of COX-2 and 5-LOX inhibitors.
Ding X; Zhu C; Qiang H; Zhou X; Zhou G
Biomed Pharmacother; 2011 Oct; 65(7):486-90. PubMed ID: 21993002
[TBL] [Abstract][Full Text] [Related]
23. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
[TBL] [Abstract][Full Text] [Related]
24. Homoharringtonine could induce quick protein synthesis of PSMD11 through activating MEK1/ERK1/2 signaling pathway in pancreatic cancer cells.
Wang L; Zhao L; Wei G; Saur D; Seidler B; Wang J; Wang C; Qi T
J Cell Biochem; 2018 Aug; 119(8):6644-6656. PubMed ID: 29665121
[TBL] [Abstract][Full Text] [Related]
25. Interlude of cGMP and cGMP/protein kinase G type 1 in pancreatic adenocarcinoma cells.
Karakhanova S; Golovastova M; Philippov PP; Werner J; Bazhin AV
Pancreas; 2014 Jul; 43(5):784-94. PubMed ID: 24826884
[TBL] [Abstract][Full Text] [Related]
26. Effect of celecoxib on proliferation, collagen expression, ERK1/2 and SMAD2/3 phosphorylation in NIH/3T3 fibroblasts.
Li F; Liu S; Ouyang Y; Fan C; Wang T; Zhang C; Zeng B; Chai Y; Wang X
Eur J Pharmacol; 2012 Mar; 678(1-3):1-5. PubMed ID: 22209876
[TBL] [Abstract][Full Text] [Related]
27. Dexamethasone inhibits basic fibroblast growth factor-stimulated gastric epithelial cell proliferation.
Luo JC; Lin HY; Lu CL; Wang LY; Chang FY; Lin HC; Huang YC; Ng KM; Chi CW; Lee SD
Biochem Pharmacol; 2008 Oct; 76(7):841-9. PubMed ID: 18692028
[TBL] [Abstract][Full Text] [Related]
28. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
Xue A; Xue M; Jackson C; Smith RC
Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
[TBL] [Abstract][Full Text] [Related]
29. Secreted 70kDa lumican stimulates growth and inhibits invasion of human pancreatic cancer.
Yamamoto T; Matsuda Y; Kawahara K; Ishiwata T; Naito Z
Cancer Lett; 2012 Jul; 320(1):31-9. PubMed ID: 22266188
[TBL] [Abstract][Full Text] [Related]
30. Adenovirus-mediated transfer of a truncated fibroblast growth factor (FGF) type I receptor blocks FGF-2 signaling in multiple pancreatic cancer cell lines.
Kleeff J; Kothari NH; Friess H; Fan H; Korc M
Pancreas; 2004 Jan; 28(1):25-30. PubMed ID: 14707726
[TBL] [Abstract][Full Text] [Related]
31. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
Guha S; Lunn JA; Santiskulvong C; Rozengurt E
Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
[TBL] [Abstract][Full Text] [Related]
32. Keratinocyte growth factor induces matrix metalloproteinase-9 expression and correlates with venous invasion in pancreatic cancer.
Cho K; Matsuda Y; Ueda J; Uchida E; Naito Z; Ishiwata T
Int J Oncol; 2012 Apr; 40(4):1040-8. PubMed ID: 22159401
[TBL] [Abstract][Full Text] [Related]
33. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
34. Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer.
Kayed H; Jiang X; Keleg S; Jesnowski R; Giese T; Berger MR; Esposito I; Löhr M; Friess H; Kleeff J
Br J Cancer; 2007 Oct; 97(8):1106-15. PubMed ID: 17876328
[TBL] [Abstract][Full Text] [Related]
35. AEE788 potentiates celecoxib-induced growth inhibition and apoptosis in human colon cancer cells.
Venkatesan P; Bhutia SK; Singh AK; Das SK; Dash R; Chaudhury K; Sarkar D; Fisher PB; Mandal M
Life Sci; 2012 Oct; 91(15-16):789-99. PubMed ID: 22922496
[TBL] [Abstract][Full Text] [Related]
36. Expression and functional perspectives of miR-184 in pancreatic ductal adenocarcinoma.
Li H; Xiang H; Ge W; Wang H; Wang T; Xiong M
Int J Clin Exp Pathol; 2015; 8(10):12313-8. PubMed ID: 26722418
[TBL] [Abstract][Full Text] [Related]
37. Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth.
Zhou C; Sun H; Zheng C; Gao J; Fu Q; Hu N; Shao X; Zhou Y; Xiong J; Nie K; Zhou H; Shen L; Fang H; Lyu J
Cell Death Dis; 2018 Feb; 9(2):161. PubMed ID: 29415987
[TBL] [Abstract][Full Text] [Related]
38. Celecoxib and GABA cooperatively prevent the progression of pancreatic cancer in vitro and in xenograft models of stress-free and stress-exposed mice.
Al-Wadei HA; Al-Wadei MH; Ullah MF; Schuller HM
PLoS One; 2012; 7(8):e43376. PubMed ID: 22916251
[TBL] [Abstract][Full Text] [Related]
39. Interactions of pancreatic cancer and stellate cells are mediated by FGFR1-III isoform expression.
Tian X; Chen G; Zhou S; Henne-Bruns D; Bachem M; Kornmann M
Hepatogastroenterology; 2012; 59(117):1604-8. PubMed ID: 22683979
[TBL] [Abstract][Full Text] [Related]
40. D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth.
Guo D; Guo J; Yao J; Jiang K; Hu J; Wang B; Liu H; Lin L; Sun W; Jiang X
Int J Cancer; 2016 Nov; 139(9):2056-67. PubMed ID: 27434219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
